Proteomics Market Synopsis

Proteomics Market Size Was Valued at USD 24.2 Billion in 2023, and is Projected to Reach USD 73.9 Billion by 2032, Growing at a CAGR of 13.2% From 2024-2032.

The proteomics market refers to the comprehensive analysis of proteins that are synthesized in an organism within a single organism focusing on large-scale description of structure function and proteins interaction. This field is vital for determining disease diagnostic markers and for drug and disease targeting that are useful in today’s management of diseases. These are the mass spectrometry, protein microarrays, bioinformatics and others that aids in analyzing proteins in the market. Proteomics is steadily rising as a research, diagnostics, and therapeutics tool because of the capacity of the discipline to discover patterns of diseases and identify pharmacological targets for the management of the diseases.

• The proteomics market, at the global level, has recorded a robust growth scenario in the recent past mainly due to emerging molecular profiling and individualized medicine forms, along with enhanced prospects in _omics_ knowledge and the effects of systems biology in combination with mass spectrometry. As a rapidly developing science, proteomics is irreplaceable in clinical research and pharma development as it provides a detailed picture of cellular processes, protein profile, and pathogenesis of numerous diseases. With the emergence of more lifestyle diseases including cancer, cardiovascular diseases and neurological disorders, proteomics is gradually increasingly as an ideal portfolio for the identification of biomarkers for early diagnostics and proper treatment. Further, liberalization of proteomics in the medication discovery process has seen the protein mapping science grow hugely as pharmaceutical organizations have purchased proteomic tools for new drug targets.
• Proteomics comes in focus of a broad variety of research fields in the year 2023 as developments in the technical procedures have enhanced the sensitivity and reliability of protein identification. The proteomics research is gaining support from the government and private organizations which in turn is fuelling the market. Big data as well as AI technologies in healthcare have improved the utilization of proteomic data to make discoveries faster and apply them to personalised medicine. In addition, academies, research laboratories, and the pharmaceutical industries have supported development of proteomic technologies, and consequently the market grows bigger. Due to its ability to identify the pathophysiological changes occurring at a molecular level, proteomics is now applied to determine disease causes and improve treatment, further promoting the development of personalized medicine.

Proteomics Market Trend Analysis

Integration with AI and Big Data

• Integrating AI and big data is arguably one of the biggest trends that is currently shaping the proteomics market. Due to huge amounts of data produced in the proteomics investigation, the fundamental approaches to data analysis have become inadequate. Modern computers employ AI and machine learning to analyse proteomics data more quickly and accurately than ever before, so they can identify protein profiles previously beyond the scope of proteomic research. It also enables the creation of pathophysiological prediction models and response to drug treatment or identification of novel therapeutic targets. Proteomics has greatly benefited from big data tools as these have enabled the processing of large datasets in a shorter time, thereby providing precise and individual information more information the areas such oncology and neurodegenerative diseases. It is believed that this trend will keep on increasing as AI technologies are enhanced more adopting into various biomedical studies.

Rise of Personalized Medicine

• Personalized medicine is one of the biggest opportunities for the proteomics market since proteomics is the key enabler for this field. The use of proteomics allows for diagnoses of more personal true biomarkers that are specific to patient’s profile promoting improvised individual measurable target drug therapies with less adverse effects. Thus, proteomics technologies get a hold of considerable scope in the market as the concern for personalised medicine persists to grow. Proteomics is slowly becoming a key factor in drug development as more pharmaceutical firms seek to develop personalized medicine based on individuals’ genetics and proteins. Also, the increasing orders for biomarker identification along with modernization of mass spectroscopy and informatics offer enormous business opportunities for proteomics companies. Investments in latest healthcare amenities in new generation economies is also anticipated to unlock new opportunities for proteomics industry particularly for cancer and chronic ailments.

Proteomics Market Segment Analysis:

Proteomics Market Segmented on the basis of Product and Service, Technology and Application.

By Product and Service, reagents & consumables segment is expected to dominate the market during the forecast period

• The reagents and consumables segment is expected to remain the largest share holder in proteomics market, with a share of 73.5% in 2023. This segment is bigger due to the large requirement of a number of reagents, kits, chemicals, and miscellaneous material required for proteomic experiments. These products are used in great detail in protein identification and quantification processes as well as analysis, therefore are a necessity in research and diagnostic fields. The demand for replenishing reagents and consumables in proteomics including mass spectrometry, protein labeling and separation methods contributes to their consistently large market share. Moreover, constant growth of the analytics of proteomes due to the progression of proteomics technologies has created a demand for high-quality reagents and, therefore, more of them. The segment has also benefited from continuous technologically enhanced and new generation specialized consumables dedicated to specific end uses that further enhanced its status as the market leader.

By Technology, Spectrometry segment expected to held the largest share

• Out of all the market segments analyzed in this research report, the spectrometry segment holds the largest share of proteomics market along with the highest CAGR of 15.2% during the forecast timeframe of 2023. Protein chemistry is one of the most important subfields of proteomics, and spectrometry, especially mass spectrometry, is the key technique that supports this field. The segment enjoys a big market share due to its high accuracy and sensitivity and compatibility with large scale protein analysis that is crucial in research, diagnostics and in drug development. Ongoing innovation in the field of spectrometry, including the mass production of high resolution mass spectrometers and better ionization methods, has also increased the use of spectrometry. Spectrometry’s role in the identification of biological markers and speeding up disease diagnosis processes, as well as in the processes of developing drugs has also played a part in the rapid growth of spectrometry. In continuation of proteomics research, spectrometry is predicted to be a significant technology that will propel research over the next few years.

Proteomics Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• The proteomics market’s regional outlook for 2023 saw North America as the most significant player in the market.. The presence of major drug makers, R&D intensive healthcare facility, and higher government budgets on R&D in this area can be cited as the main reasons for regional leadership. Among the leading market players, the United States is expected to command the largest share due to the advancing application of precision medicine, combined with growing interest in genomics and proteomics. North America is expected to dominate the global proteomics market by contributing about 40 to 45% of the overall market in 2023. This dominance is also reflected by the increasing number of proteomics academic-industry partnerships identified in this study. The funding for proteomics studies in the region especially in the fields of cancer as well as drug discovery has created a behaviour in the North American region that puts it at the helm of the international market. Furthermore, it has been driven by positive regulatory environments and the presence of first-tier proteomics industries in the region.

Active Key Players in the Proteomics Market

• Agilent Technologies (USA)
• Becton, Dickinson and Company (USA)
• Bio-Rad Laboratories (USA)
• Bruker Corporation (USA)
• Creative Proteomics (USA)
• Danaher Corporation (USA)
• GE Healthcare (UK)
• Horiba, Ltd. (Japan)
• Luminex Corporation (USA)
• Merck KGaA (Germany)
• PerkinElmer (USA)
• Promega Corporation (USA)
• Shimadzu Corporation (Japan)
• Thermo Fisher Scientific (USA)
• Waters Corporation (USA)
• Other key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Proteomics Market by Product and Service
 4.1 Proteomics Market Snapshot and Growth Engine
 4.2 Proteomics Market Overview
 4.3 Instruments
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Instruments: Geographic Segmentation Analysis
 4.4 Reagents & Consumables
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Reagents & Consumables: Geographic Segmentation Analysis
 4.5 Services
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Services: Geographic Segmentation Analysis

Chapter 5: Proteomics Market by Technology
 5.1 Proteomics Market Snapshot and Growth Engine
 5.2 Proteomics Market Overview
 5.3 Next-generation Sequencing
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Next-generation Sequencing: Geographic Segmentation Analysis
 5.4 Microarray Instruments
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Microarray Instruments: Geographic Segmentation Analysis
 5.5 X-ray crystallography
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 X-ray crystallography: Geographic Segmentation Analysis
 5.6 Spectrometry
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Spectrometry: Geographic Segmentation Analysis
 5.7 Chromatography
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Chromatography: Geographic Segmentation Analysis
 5.8 Protein Fractionation Systems
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Protein Fractionation Systems: Geographic Segmentation Analysis
 5.9 Electrophoresis
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Electrophoresis: Geographic Segmentation Analysis
 5.10 Surface Plasma Resonance Systems
  5.10.1 Introduction and Market Overview
  5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.10.3 Key Market Trends, Growth Factors and Opportunities
  5.10.4 Surface Plasma Resonance Systems: Geographic Segmentation Analysis

Chapter 6: Proteomics Market by Application
 6.1 Proteomics Market Snapshot and Growth Engine
 6.2 Proteomics Market Overview
 6.3 Drug Discovery
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Drug Discovery: Geographic Segmentation Analysis
 6.4 Clinical Diagnostics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Clinical Diagnostics: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Proteomics Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 AGILENT TECHNOLOGIES (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 BECTON
 7.4 DICKINSON AND COMPANY (USA)
 7.5 BIO-RAD LABORATORIES (USA)
 7.6 BRUKER CORPORATION (USA)
 7.7 OTHER ACTIVE PLAYERS

Chapter 8: Global Proteomics Market By Region
 8.1 Overview
 8.2. North America Proteomics Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product and Service
  8.2.4.1 Instruments
  8.2.4.2 Reagents & Consumables
  8.2.4.3 Services
  8.2.5 Historic and Forecasted Market Size By Technology
  8.2.5.1 Next-generation Sequencing
  8.2.5.2 Microarray Instruments
  8.2.5.3 X-ray crystallography
  8.2.5.4 Spectrometry
  8.2.5.5 Chromatography
  8.2.5.6 Protein Fractionation Systems
  8.2.5.7 Electrophoresis
  8.2.5.8 Surface Plasma Resonance Systems
  8.2.6 Historic and Forecasted Market Size By Application
  8.2.6.1 Drug Discovery
  8.2.6.2 Clinical Diagnostics
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Proteomics Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product and Service
  8.3.4.1 Instruments
  8.3.4.2 Reagents & Consumables
  8.3.4.3 Services
  8.3.5 Historic and Forecasted Market Size By Technology
  8.3.5.1 Next-generation Sequencing
  8.3.5.2 Microarray Instruments
  8.3.5.3 X-ray crystallography
  8.3.5.4 Spectrometry
  8.3.5.5 Chromatography
  8.3.5.6 Protein Fractionation Systems
  8.3.5.7 Electrophoresis
  8.3.5.8 Surface Plasma Resonance Systems
  8.3.6 Historic and Forecasted Market Size By Application
  8.3.6.1 Drug Discovery
  8.3.6.2 Clinical Diagnostics
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Proteomics Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product and Service
  8.4.4.1 Instruments
  8.4.4.2 Reagents & Consumables
  8.4.4.3 Services
  8.4.5 Historic and Forecasted Market Size By Technology
  8.4.5.1 Next-generation Sequencing
  8.4.5.2 Microarray Instruments
  8.4.5.3 X-ray crystallography
  8.4.5.4 Spectrometry
  8.4.5.5 Chromatography
  8.4.5.6 Protein Fractionation Systems
  8.4.5.7 Electrophoresis
  8.4.5.8 Surface Plasma Resonance Systems
  8.4.6 Historic and Forecasted Market Size By Application
  8.4.6.1 Drug Discovery
  8.4.6.2 Clinical Diagnostics
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Proteomics Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product and Service
  8.5.4.1 Instruments
  8.5.4.2 Reagents & Consumables
  8.5.4.3 Services
  8.5.5 Historic and Forecasted Market Size By Technology
  8.5.5.1 Next-generation Sequencing
  8.5.5.2 Microarray Instruments
  8.5.5.3 X-ray crystallography
  8.5.5.4 Spectrometry
  8.5.5.5 Chromatography
  8.5.5.6 Protein Fractionation Systems
  8.5.5.7 Electrophoresis
  8.5.5.8 Surface Plasma Resonance Systems
  8.5.6 Historic and Forecasted Market Size By Application
  8.5.6.1 Drug Discovery
  8.5.6.2 Clinical Diagnostics
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Proteomics Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product and Service
  8.6.4.1 Instruments
  8.6.4.2 Reagents & Consumables
  8.6.4.3 Services
  8.6.5 Historic and Forecasted Market Size By Technology
  8.6.5.1 Next-generation Sequencing
  8.6.5.2 Microarray Instruments
  8.6.5.3 X-ray crystallography
  8.6.5.4 Spectrometry
  8.6.5.5 Chromatography
  8.6.5.6 Protein Fractionation Systems
  8.6.5.7 Electrophoresis
  8.6.5.8 Surface Plasma Resonance Systems
  8.6.6 Historic and Forecasted Market Size By Application
  8.6.6.1 Drug Discovery
  8.6.6.2 Clinical Diagnostics
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Proteomics Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product and Service
  8.7.4.1 Instruments
  8.7.4.2 Reagents & Consumables
  8.7.4.3 Services
  8.7.5 Historic and Forecasted Market Size By Technology
  8.7.5.1 Next-generation Sequencing
  8.7.5.2 Microarray Instruments
  8.7.5.3 X-ray crystallography
  8.7.5.4 Spectrometry
  8.7.5.5 Chromatography
  8.7.5.6 Protein Fractionation Systems
  8.7.5.7 Electrophoresis
  8.7.5.8 Surface Plasma Resonance Systems
  8.7.6 Historic and Forecasted Market Size By Application
  8.7.6.1 Drug Discovery
  8.7.6.2 Clinical Diagnostics
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research